| Followers | 38 |
| Posts | 9607 |
| Boards Moderated | 0 |
| Alias Born | 12/18/2014 |
Wednesday, April 22, 2020 1:39:38 AM
"remdesivir only drug showed signs of effectiveness"
https://www.bbc.com/news/health-52354520
What is the most promising coronavirus drug?
Dr Bruce Aylward, from the World Health Organization, said remdesivir was the only drug that showed any signs of effectiveness, after he visited China.
The antiviral drug was originally designed to treat Ebola, but other options proved more effective.
It has since been shown to be effective at treating other deadly coronaviruses (Middle East respiratory syndrome and severe acute respiratory syndrome) in animal studies, leading to hopes it will also be effective against the Covid-19 coronavirus.
Leaked results from trials led by the University of Chicago also suggested the drug was effective.
It is one of the four drugs in the WHO Solidarity trial and its manufacturer, Gilead, is also organising trials.
https://www.bbc.com/news/health-52354520
What is the most promising coronavirus drug?
Dr Bruce Aylward, from the World Health Organization, said remdesivir was the only drug that showed any signs of effectiveness, after he visited China.
The antiviral drug was originally designed to treat Ebola, but other options proved more effective.
It has since been shown to be effective at treating other deadly coronaviruses (Middle East respiratory syndrome and severe acute respiratory syndrome) in animal studies, leading to hopes it will also be effective against the Covid-19 coronavirus.
Leaked results from trials led by the University of Chicago also suggested the drug was effective.
It is one of the four drugs in the WHO Solidarity trial and its manufacturer, Gilead, is also organising trials.
Recent GILD News
- Tempus AI Shares Gain After Expanded Partnership with Gilead • IH Market News • 04/10/2026 01:34:23 PM
- Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline • Business Wire • 04/07/2026 12:30:00 PM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 04/01/2026 08:34:18 PM
- Gilead Extends Tender Offer to Acquire Arcellx • Business Wire • 04/01/2026 08:13:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/30/2026 09:59:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/27/2026 08:03:17 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/26/2026 10:40:06 PM
- Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases • Business Wire • 03/23/2026 10:15:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/20/2026 08:01:13 PM
- Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care • PR Newswire (US) • 03/19/2026 02:00:00 PM
- Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care • PR Newswire (Canada) • 03/19/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 10:56:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 10:14:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/16/2026 08:06:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/16/2026 08:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:45:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:42:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:37:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:24:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:22:25 PM
- Form SC TO-T - Tender offer statement by Third Party • Edgar (US Regulatory) • 03/06/2026 09:55:42 PM
- Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion • PR Newswire (Canada) • 03/03/2026 02:00:00 PM
- Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 09:54:14 PM
